Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group (Q74038855)
Jump to navigation
Jump to search
scientific article published on 01 January 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group |
scientific article published on 01 January 1998 |
Statements
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group (English)
Vincenti F
Kirkman R
Light S
Bumgardner G
Pescovitz M
Neylan J
Wilkinson A
Ekberg H
Gaston R
Backman L